Science Explorer Interactive view Map
Company · Munich · Germany

Astellas Pharma (Germany)

astellas.deROR OpenAlex
Research works
68
▼ 64% vs 2013–17
Citations
1.4k
20.0 per fractional work
Top-10% rate
2.4%
record average 16.5%
Open access
23%
world 28%

Not ranked overall: Astellas Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.23× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.98× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 21.40× its world share, 1 worksPharmacology, Toxico…Energy: 0.78× its world share, 0 worksEnergyEngineering: 0.26× its world share, 1 worksEngineeringEnvironmental Science: 0.43× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 0.65× its world share, 0 worksPhysics and AstronomyHealth Professions: 3.68× its world share, 2 worksHealth ProfessionsMedicine: 2.15× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.39× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 12.69× its world share, 4 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 21.4×. Every wedge is a field page.

Which keywords describe research at Astellas Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pharmaceutical Industry, Kidney Transplantation, Graft Survival, Urinary Incontinence, Immunosuppressive Drugs, Clinical Trials and Genetic Variation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology6▲ 2.4×18 topics
  2. Graft Survival3▲ 47×2 topics
  3. Kidney Transplantation3▲ 73×2 topics
  4. Pharmaceutical Industry3▲ 125×2 topics
  5. Urinary Incontinence3▲ 54×2 topics
  6. Inflammation3▲ 1.97×9 topics
  7. Clinical Trials3▲ 7.0×6 topics
  8. Immunosuppressive Drugs3▲ 65×2 topics
  9. Genetic Variation3▲ 12×3 topics
  10. Antibody-Mediated Rejection2▲ 88×1 topic
  11. Benign Prostatic Hyperplasia2▲ 90×1 topic
  12. Lower Urinary Tract Symptoms2▲ 90×1 topic
  13. Model Checking2▲ 34×3 topics
  14. Renal Allograft2▲ 88×1 topic
  15. Antimicrobial Resistance2▲ 14×5 topics
  16. Drug Discovery2▲ 8.9×3 topics
  17. Drug Development Costs2▲ 132×1 topic
  18. Ethical Considerations2▲ 10×3 topics
  19. Generic Drugs2▲ 132×1 topic
  20. Treatment2▲ 2.6×11 topics
  21. Primary Care2▲ 6.9×2 topics
  22. Stress2▲ 7.3×2 topics
  23. Clinical Guidelines2▲ 9.0×4 topics
  24. Catheter-Associated Infections2▲ 75×1 topic
  25. Cytochrome P4502▲ 38×2 topics
  26. Immunotherapy2▲ 3.9×6 topics
  27. Urinary Tract Infections2▲ 59×1 topic
  28. Serotonin2▲ 37×2 topics
  29. Antifungal Therapy2▲ 24×3 topics
  30. Transplantation2▲ 21×2 topics
  31. Cell Signaling2▲ 6.6×2 topics
  32. Health Care Spending2▲ 34×1 topic
  33. Insurance Markets2▲ 34×1 topic
  34. Publication Bias2▲ 41×2 topics
  35. Asthma1▲ 16×2 topics
  36. Pharmacology1▲ 6.3×3 topics
  37. Dopamine1▲ 36×1 topic
  38. Prostate Cancer1▲ 13×3 topics
  39. Reward Circuitry1▲ 36×1 topic
  40. Temporal Logic1▲ 26×2 topics

Which research topics does Astellas Pharma (Germany) publish most on?

By volume in 2022–2025: Pharmaceutical Economics and Policy, Healthcare Policy and Management, Global Health and Surgery and Medical Malpractice and Liability Issues.

Pharmaceutical Economics…2Pharmaceutical Economics and Policy: 2 fractional worksHealthcare Policy and Management: 2 fractional worksGlobal Health and Surgery: 1 fractional worksMedical Malpractice and Liability Issues: 1 fractional worksBiotechnology and Related Fields: 1 fractional worksPharmaceutical industry …1Pharmaceutical industry and healthcare: 1 fractional worksBiomedical Ethics and Regulation: 1 fractional worksBiomedical and Engineering Education: 0 fractional worksArtificial Intelligence in Healthcare and Education: 0 fractional worksPrimary Care and Health Outcomes: 0 fractional works
Economics and EconometricsPublic Health, Environmental and Occupational HealthPharmacyPharmacology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
  2. 2 Healthcare Policy and Management Economics and Econometrics 2 works
  3. 3 Global Health and Surgery Public Health, Environmental and Occupational Health 1 works
  4. 4 Medical Malpractice and Liability Issues Pharmacy 1 works
  5. 5 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
  6. 6 Pharmaceutical industry and healthcare Pharmacology 1 works
  7. 7 Biomedical Ethics and Regulation Physiology 1 works
  8. 8 Biomedical and Engineering Education Biomedical Engineering 0 works
  9. 9 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
  10. 10 Primary Care and Health Outcomes General Health Professions 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.3%not open76.7%

World: 28% of research is openly available.

with international co-authors39.2%domestic only60.8%

World: 19% is written across borders.

How has Astellas Pharma (Germany)'s research output changed?

Output in 2018–2022 was 64% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Munich

All research institutions in Munich

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.